Angie Balfour

Western General Hospital

Papers

1

Total Citations

14

H-Index

1

About

Angie Balfour is a clinical researcher whose work centres on perioperative medicine and enhanced recovery after surgery (ERAS), with a particular focus on improving gastrointestinal recovery following colorectal procedures. Her most notable contribution is as lead author of the landmark ALLEGRO trial (2022), a placebo-controlled randomised study investigating intravenous lidocaine’s role in accelerating return of GI function after colorectal surgery. This work addresses a critical clinical challenge—delayed GI recovery affects up to 40% of patients, causing significant morbidity and prolonged hospital stays. While the ALLEGRO trial has garnered 14 citations to date, its impact extends beyond raw numbers, as it provides high-quality evidence for a widely debated intervention in enhanced recovery pathways. Balfour’s research bridges the gap between anaesthetic pharmacology and surgical outcomes, offering practical insights for clinicians seeking to reduce postoperative ileus. Her work is particularly valuable for students and researchers interested in evidence-based perioperative care, as it exemplifies how rigorous trial design can clarify the role of established drugs in new contexts. Balfour continues to contribute to the growing body of literature aimed at optimising patient recovery and reducing complications after major abdominal surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
The ALLEGRO trial: a placebo controlled randomised trial of intravenous lidocaine in accelerating gastrointestinal recovery after colorectal surgery
14 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Western General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago